In randomized controlled trials, there are two treatment alternatives currently considered the standard of care in Guillain-Barré syndrome (GBS). These include possibly intravenous immunoglobulin (IVIG) or plasma https://bookmarksurl.com/story3543530/top-guillain-barre-syndrome-physiotherapy-vasant-kunj-secrets